FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

标题
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 100, Issue 11, Pages 1739-1745
出版商
Springer Nature
发表日期
2009-05-13
DOI
10.1038/sj.bjc.6605076

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started